Customer Service: Write to info1@cyno.co.in
Loading...
To provide you with a better shopping experience, our website is currently being upgraded.
为了提供更好的服务，我们的网站正在进行升级。
During this period, please place your order through our Official Partner Ordering Page using the button below.
升级期间，请通过下方官方合作伙伴订购页面下单。
We appreciate your understanding and continued support.
感谢您的理解与支持。
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
